Emilie Mamessier

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 15

Top Venues

Cancers

Pharmaceutics

Molecular cancer therapeutics

Journal of personalized medicine

INSERM Délégation régionale Provence Alpes Cote d'Azur et Corse

Aix-Marseille Université Faculté de Medecine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

INSERM Délégation régionale Provence Alpes Cote d'Azur et Corse Sep 01 2012

France

CR1 :: 13

Education History

Aix-Marseille Université Faculté de Medecine Sep 01 2002 - Dec 01 2005

France

PHD

Publications

David Jeremie Birnbaum, Maelle Picard, Quentin Da Costa, Thomas Delayre, Pascal Finetti, Olivier Cabaud, Emilie Agavnian, Bernadette De Rauglaudre, Emilie Denicolaï, François Bertucci, Emilie Mamessier
PVRIG Expression Is an Independent Prognostic Factor and a New Potential Target for Immunotherapy in Hepatocellular Carcinoma. Cancers 15 (2) (2023)
Alexandre de Nonneville, Pascal Finetti, Laurys Boudin, Emilie Denicolaï, Daniel Birnbaum, Emilie Mamessier, François Bertucci
Prognostic and Predictive Value of LIV1 Expression in Early Breast Cancer and by Molecular Subtype. Pharmaceutics 15 (3) (2023)
David Jeremie Birnbaum, Maelle Picard, Quentin Da Costa, Thomas Delayre, Pascal Finetti, Olivier Cabaud, Emilie Agavnian, Bernadette De Rauglaudre, Emilie Denicolaï, François Bertucci, Emilie Mamessier
PVRIG Expression Is an Independent Prognostic Factor and a New Potential Target for Immunotherapy in Hepatocellular Carcinoma. Cancers 15 (2) (2023)
Alexandre de Nonneville, Pascal Finetti, Laurys Boudin, Emilie Denicolaï, Daniel Birnbaum, Emilie Mamessier, François Bertucci
Prognostic and Predictive Value of LIV1 Expression in Early Breast Cancer and by Molecular Subtype. Pharmaceutics 15 (3) (2023)
Alexandre de Nonneville, Pascal Finetti, Laurys Boudin, Emilie Denicolaï, Daniel Birnbaum, Emilie Mamessier, François Bertucci
Prognostic and Predictive Value of LIV1 Expression in Early Breast Cancer and by Molecular Subtype. Pharmaceutics 15 (3) (2023)
Olivier Cabaud, Ludovic Berger, Emerence Crompot, José Adélaide, Pascal Finetti, Sèverine Garnier, Arnaud Guille, Nadine Carbuccia, Anne Farina, Emilie Agavnian, Max Chaffanet, Anthony Goncalves, Emmanuelle Charafe-Jauffret, Emilie Mamessier, Daniel Birnbaum, François Bertucci, Marc Lopez
Overcoming Resistance to Anti-Nectin-4 Antibody-Drug Conjugate. Molecular cancer therapeutics 21 (7) (2022)
Emilien Billon, Gwenaelle Gravis, Arnaud Guille, Nadine Carbuccia, Jose Adelaide, Séverine Garnier, Pascal Finetti, Emilie Denicolaï, Patrick Sfumato, Serge Brunelle, Jeanne Thomassin-Piana, Géraldine Pignot, Jochen Walz, Christian Chabanon, Jihane Pakradouni, Renaud Sabatier, Cécile Vicier, Cornel Popovici, Emilie Mamessier, Anthony Goncalves, Daniel Birnbaum, Max Chaffanet, François Bertucci
Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial. Cancers 14 (9) (2022)
Mathias Neron, Arnaud Guille, Lucie Allegre, Pierre-Emmanuel Colombo, Cristina Leaha, José Adelaide, Nadine Carbuccia, Frédéric Courtier, Florence Boissière, Evelyne Lopez-Crapez, Michel Fabbro, Sébastien Gouy, Emilie Mamessier, Éric Lambaudie, Daniel Birnbaum, François Bertucci, Max Chaffanet
Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone Therapy. Journal of personalized medicine 12 (5) (2022)
Alexia Mélanie Lopresti, Claire Acquaviva, Laurys Boudin, Pascal Finetti, Séverine Garnier, Anaïs Aulas, Maria Lucia Liberatoscioli, Olivier Cabaud, Arnaud Guille, Alexandre de Nonneville, Quentin Da Costa, Emilie Denicolai, Jihane Pakradouni, Anthony Goncalves, Daniel Birnbaum, François Bertucci, Emilie Mamessier
Identification of Atypical Circulating Tumor Cells with Prognostic Value in Metastatic Breast Cancer Patients. Cancers 14 (4) (2022)
Alexandre de Nonneville, Pascal Finetti, Maelle Picard, Audrey Monneur, Maria Abbondanza Pantaleo, Annalisa Astolfi, Jerzy Ostrowski, Daniel Birnbaum, Emilie Mamessier, François Bertucci
CSPG4 Expression in GIST Is Associated with Better Prognosis and Strong Cytotoxic Immune Response. Cancers 14 (5) (2022)
Laurys Boudin, Alexandre de Nonneville, Pascal Finetti, Geoffrey C Guittard, Jacques A Nunès, Daniel Birnbaum, Emilie Mamessier, François Bertucci
CISH Expression Is Associated with Metastasis-Free Interval in Triple-Negative Breast Cancer and Refines the Prognostic Value of PDL1 Expression. Cancers 14 (14) (2022)
Bernadette de Rauglaudre, Pascal Finetti, David Jérémie Birnbaum, Marc Lopez, François Bertucci, Emilie Mamessier
First-in-Human, Phase I Study of PCA062 in Solid Tumors-Letter. Molecular cancer therapeutics 21 (11) (2022)
Conception Paul, Ruizhi Tang, Ciro Longobardi, Rossano Lattanzio, Thibaut Eguether, Hulya Turali, Julie Bremond, Chloé Maurizy, Monica Gabola, Sophie Poupeau, Andrei Turtoi, Emilie Denicolai, Maria Concetta Cufaro, Magali Svrcek, Philippe Seksik, Vincent Castronovo, Philippe Delvenne, Vincenzo de Laurenzi, Quentin Da Costa, François Bertucci, Bénédicte Lemmers, Damiana Pieragostino, Emilie Mamessier, Carsten Janke, Valérie Pinet, Michael Hahne
Loss of primary cilia promotes inflammation and carcinogenesis. EMBO reports 23 (12) (2022)
Guillaume Belthier, Zeinab Homayed, Fanny Grillet, Christophe Duperray, Julie Vendrell, Ilona Krol, Sophie Bravo, Jean-Christophe Boyer, Olivia Villeronce, Jihane Vitre-Boubaker, Diana Heaug-Wane, Françoise Macari, Jai Smith, Matthieu Merlot, Gérald Lossaint, Thibault Mazard, Fabienne Portales, Jean-Marc Rey, Marc Ychou, Nicola Aceto, Emilie Mamessier, François Bertucci, Jean Marc Pascussi, Emmanuelle Samalin, Frédéric Hollande, Julie Pannequin
CD44v6 Defines a New Population of Circulating Tumor Cells Not Expressing EpCAM. Cancers 13 (19) (2021)
Anaïs Aulas, Pascal Finetti, Shawn M Lyons, François Bertucci, Daniel Birnbaum, Claire Acquaviva, Emilie Mamessier
Revisiting the Concept of Stress in the Prognosis of Solid Tumors: A Role for Stress Granules Proteins? Cancers 12 (9) (2020)

Emilie Mamessier.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Emilie Mamessier